Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis

NCT00004285 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1846

Last updated 2017-09-14

No results posted yet for this study

Summary

OBJECTIVES: I. Evaluate whether hemodialysis providing a 2-pool, variable volume urea kinetic modelling value of 1.05 versus 1.45 reduces mortality and morbidity in patients with end stage renal disease.

II. Compare the efficacy of high versus low flux dialyzer membranes.

Conditions

Interventions

DEVICE

Standard dose, low flux hemodialysis

DEVICE

Standard dose, high flux hemodialysis

DEVICE

High dose, low flux hemodialysis

DEVICE

High dose, high flux hemodialysis

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER
  • The Cleveland Clinic

    collaborator OTHER
  • Tufts Medical Center

    collaborator OTHER
  • Vanderbilt University

    collaborator OTHER
  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    collaborator OTHER
  • Washington University School of Medicine

    collaborator OTHER
  • University of Illinois at Chicago

    collaborator OTHER
  • Main Line Health

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • Duke University

    collaborator OTHER
  • University of Texas Southwestern Medical Center

    collaborator OTHER
  • Brigham and Women's Hospital

    collaborator OTHER
  • Wake Forest University Health Sciences

    collaborator OTHER
  • University of Utah

    collaborator OTHER
  • University of California, Davis

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    lead NIH

Principal Investigators

  • Daniel B. Ornt · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-03-31
Primary Completion
2001-12-31
Completion
2001-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004285 on ClinicalTrials.gov